• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未能达到目标体重与接受维持性血液透析患者的短期住院相关。

Failed Target Weight Achievement Associates with Short-Term Hospital Encounters among Individuals Receiving Maintenance Hemodialysis.

机构信息

University of North Carolina Kidney Center, Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina.

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina; and.

出版信息

J Am Soc Nephrol. 2018 Aug;29(8):2178-2188. doi: 10.1681/ASN.2018010004. Epub 2018 May 23.

DOI:10.1681/ASN.2018010004
PMID:29793962
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6065090/
Abstract

Hospitalizations and 30-day readmissions are common in the hemodialysis population. Actionable clinical markers for near-term hospital encounters are needed to identify individuals who require swift intervention to avoid hospitalization. Aspects of volume management, such as failed target weight (i.e, estimated dry weight) achievement, are plausible modifiable indicators of impending adverse events. The short-term consequences of failed target weight achievement are not well established. Statistically deidentified data were taken from a cohort of Medicare-enrolled, prevalent hemodialysis patients treated at a large dialysis organization from 2010 to 2012. We used a retrospective cohort design with repeated intervals, each consisting of 180-day baseline, 30-day exposure assessment, and 30-day follow-up period, to estimate the associations between failed target weight achievement and the risk of 30-day emergency department visits and hospitalizations. We estimated adjusted risk differences using inverse probability of exposure weighted Kaplan-Meier methods. A total of 113,561 patients on hemodialysis contributed 788,722 study intervals to analyses. Patients who had a postdialysis weight >1.0 kg above the prescribed target weight in ≥30% (versus <30%) of exposure period treatments had a higher absolute risk (risk difference) of 30-day: emergency department visits (2.13%; 95% confidence interval, 2.00% to 2.32%); and all-cause (1.47%; 95% confidence interval, 1.34% to 1.62%), cardiovascular (0.31%; 95% confidence interval, 0.24% to 0.40%), and volume-related (0.15%; 95% confidence interval, 0.11% to 0.21%) hospitalizations. In the absence of objective measures of volume status, recurrent failure to achieve target weight is an easily identifiable clinical risk marker for impending hospital encounters among patients on hemodialysis.

摘要

住院和 30 天内再入院在血液透析人群中很常见。需要有可操作的临床指标来识别那些需要迅速干预以避免住院的个体。容量管理的各个方面,如未能达到目标体重(即估计干体重),是即将发生不良事件的合理可改变指标。未能达到目标体重的短期后果尚未得到很好的确定。从 2010 年至 2012 年,在一家大型透析机构接受治疗的医疗保险登记的普遍血液透析患者队列中,我们从统计学上确定了匿名数据。我们使用了具有重复间隔的回顾性队列设计,每个间隔包括 180 天的基线、30 天的暴露评估和 30 天的随访期,以估计未能达到目标体重与 30 天急诊就诊和住院风险之间的关系。我们使用逆概率暴露加权 Kaplan-Meier 方法估计调整后的风险差异。共有 113561 名血液透析患者为 788722 个研究间隔做出了贡献。与暴露期治疗中(<30%)有≥30%的透析后体重超过规定目标体重 1.0 公斤以上的患者相比,他们的 30 天绝对风险(风险差异)更高:急诊就诊(2.13%;95%置信区间,2.00%至 2.32%);全因(1.47%;95%置信区间,1.34%至 1.62%)、心血管(0.31%;95%置信区间,0.24%至 0.40%)和容量相关(0.15%;95%置信区间,0.11%至 0.21%)住院治疗。在没有容量状态的客观指标的情况下,未能反复达到目标体重是血液透析患者即将发生医院就诊的一个易于识别的临床风险标志物。

相似文献

1
Failed Target Weight Achievement Associates with Short-Term Hospital Encounters among Individuals Receiving Maintenance Hemodialysis.未能达到目标体重与接受维持性血液透析患者的短期住院相关。
J Am Soc Nephrol. 2018 Aug;29(8):2178-2188. doi: 10.1681/ASN.2018010004. Epub 2018 May 23.
2
Intradialytic Hypertension Frequency and Short-Term Clinical Outcomes Among Individuals Receiving Maintenance Hemodialysis.维持性血液透析患者透析中高血压的发生频率及其短期临床结局。
Am J Hypertens. 2018 Feb 9;31(3):329-339. doi: 10.1093/ajh/hpx186.
3
Readmissions Following a Hospitalization for Cardiovascular Events in Dialysis Patients: A Retrospective Cohort Study.透析患者心血管事件住院后再入院情况:一项回顾性队列研究。
J Am Heart Assoc. 2018 Feb 13;7(4):e007231. doi: 10.1161/JAHA.117.007231.
4
Prior Hospitalization Burden and the Relatedness of 30-Day Readmissions in Patients Receiving Hemodialysis.接受血液透析患者的住院负担与 30 天再入院的相关性。
J Am Soc Nephrol. 2019 Feb;30(2):323-335. doi: 10.1681/ASN.2018080858. Epub 2019 Jan 3.
5
Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.血液透析后体重高于和低于目标体重与全因死亡率和心血管死亡率的关联。
Clin J Am Soc Nephrol. 2015 May 7;10(5):808-16. doi: 10.2215/CJN.10201014. Epub 2015 Apr 10.
6
Clinical outcomes after parathyroidectomy in a nationwide cohort of patients on hemodialysis.全国范围内接受血液透析患者甲状旁腺切除术后的临床结局
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):90-7. doi: 10.2215/CJN.03520414. Epub 2014 Dec 16.
7
Post-hospitalization dialysis facility processes of care and hospital readmissions among hemodialysis patients: a retrospective cohort study.血液透析患者出院后透析设施的护理流程与再入院情况:一项回顾性队列研究
BMC Nephrol. 2018 Jul 31;19(1):186. doi: 10.1186/s12882-018-0983-5.
8
Association of Smoking Status With Mortality and Hospitalization in Hemodialysis Patients.吸烟状况与血液透析患者死亡率和住院率的关系。
Am J Kidney Dis. 2018 Nov;72(5):673-681. doi: 10.1053/j.ajkd.2018.04.004. Epub 2018 Jun 15.
9
Outcomes of infection-related hospitalization in Medicare beneficiaries receiving in-center hemodialysis.接受中心血液透析的医疗保险受益人与感染相关的住院治疗结果。
Am J Kidney Dis. 2015 May;65(5):754-62. doi: 10.1053/j.ajkd.2014.11.030. Epub 2015 Jan 30.
10
Physician visits and 30-day hospital readmissions in patients receiving hemodialysis.接受血液透析患者的门诊就诊及30天内再入院情况
J Am Soc Nephrol. 2014 Sep;25(9):2079-87. doi: 10.1681/ASN.2013080879. Epub 2014 May 8.

引用本文的文献

1
I Brazilian guideline on hypertension in dialysis of the Brazilian Society of Nephrology.我是巴西肾脏病学会巴西透析高血压指南。 (此译文逻辑较怪,原英文表述不太完整准确,可能正确表述是:我是巴西肾脏病学会发布的巴西透析高血压指南 ) 按现有英文直接翻译就是这样,供你参考。
J Bras Nefrol. 2025 Jan-Mar;47(1):e20240033. doi: 10.1590/2175-8239-JBN-2024-0033en.
2
Standardizing Blood Pressure Measurements in Pediatric Hemodialysis: a Collaborative Journey.规范儿科血液透析中的血压测量:协作之旅。
Curr Hypertens Rep. 2023 Oct;25(10):329-334. doi: 10.1007/s11906-023-01255-3. Epub 2023 Jul 28.
3
Emergency Department Utilization Among Maintenance Hemodialysis Patients: A Systematic Review.维持性血液透析患者的急诊科利用率:一项系统评价
Kidney Med. 2021 Dec 3;4(2):100391. doi: 10.1016/j.xkme.2021.09.007. eCollection 2022 Feb.
4
Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease.与终末期肾病血液透析相关的炎症和心血管疾病
Front Pharmacol. 2022 Feb 10;13:800950. doi: 10.3389/fphar.2022.800950. eCollection 2022.
5
Implementing a fluid volume management program to decrease intra-dialytic hypotensive events in a paediatric in-centre haemodialysis unit: a quality improvement project.实施液体容量管理方案以降低儿科中心血液透析单元内透析中低血压事件发生率:一项质量改进项目。
Pediatr Nephrol. 2022 May;37(5):1105-1115. doi: 10.1007/s00467-021-05298-z. Epub 2021 Oct 13.
6
Progress in volume assessment for the hemodialysis patients.血液透析患者容量评估的进展。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Jul 28;46(7):759-766. doi: 10.11817/j.issn.1672-7347.2021.200783.
7
Blood pressure and volume management in dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.透析中的血压与容量管理:来自改善全球肾脏病预后(KDIGO)争议会议的结论
Kidney Int. 2020 May;97(5):861-876. doi: 10.1016/j.kint.2020.01.046. Epub 2020 Mar 8.
8
Thinking Volume First: Developing a Multifaceted Systematic Approach to Volume Management in Hemodialysis.优先考虑容量:开发一种多方面的系统性血液透析容量管理方法。
Can J Kidney Health Dis. 2019 Sep 26;6:2054358119879776. doi: 10.1177/2054358119879776. eCollection 2019.
9
The relationship of volume overload and its control to hypertension in hemodialysis patients.血液透析患者容量超负荷及其控制与高血压的关系。
Semin Dial. 2019 Nov;32(6):500-506. doi: 10.1111/sdi.12838. Epub 2019 Sep 29.
10
Ultrafiltration-profiled hemodialysis to reduce dialysis-related cardiovascular stress: Study protocol for a randomized controlled trial.超滤模式血液透析以减轻透析相关心血管应激:一项随机对照试验的研究方案
Contemp Clin Trials Commun. 2019 Jul 19;15:100415. doi: 10.1016/j.conctc.2019.100415. eCollection 2019 Sep.

本文引用的文献

1
The Journey to Full Health Care Responsibility for One ESCO Provider.一位ESCO供应商实现全面医疗保健责任的历程。
Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2050-2052. doi: 10.2215/CJN.05520517. Epub 2017 Oct 30.
2
Right TraC™ Post-Hospitalization Care Transitions Program to Reduce Readmissions for Hemodialysis Patients.Right TraC™ 住院后护理过渡计划,以减少血液透析患者的再入院率。
Am J Nephrol. 2017;45(6):532-539. doi: 10.1159/000477325. Epub 2017 May 23.
3
US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States.《美国肾脏数据系统2016年年报:美国肾脏疾病流行病学》
Am J Kidney Dis. 2017 Mar;69(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2016.12.004.
4
Identification of Emergency Department Visits in Medicare Administrative Claims: Approaches and Implications.医疗保险行政索赔中急诊科就诊情况的识别:方法与影响
Acad Emerg Med. 2017 Apr;24(4):422-431. doi: 10.1111/acem.13140. Epub 2017 Mar 17.
5
Identification of volume overload hospitalizations among hemodialysis patients using administrative claims: a validation study.使用行政索赔识别血液透析患者中的容量超负荷住院情况:一项验证研究。
BMC Nephrol. 2016 Nov 11;17(1):173. doi: 10.1186/s12882-016-0384-6.
6
Predicting mortality over different time horizons: which data elements are needed?预测不同时间范围内的死亡率:需要哪些数据元素?
J Am Med Inform Assoc. 2017 Jan;24(1):176-181. doi: 10.1093/jamia/ocw057. Epub 2016 Jun 29.
7
Reducing hospital readmissions in patients with end-stage kidney disease.降低终末期肾病患者的医院再入院率。
Kidney Int. 2015 Dec;88(6):1250-1260. doi: 10.1038/ki.2015.307. Epub 2015 Oct 14.
8
Comparative Short-term Safety of Sodium Ferric Gluconate Versus Iron Sucrose in Hemodialysis Patients.比较葡萄糖酸铁钠与蔗糖铁在血液透析患者中的短期安全性。
Am J Kidney Dis. 2016 Jan;67(1):119-27. doi: 10.1053/j.ajkd.2015.07.026. Epub 2015 Sep 16.
9
Associations of Posthemodialysis Weights above and below Target Weight with All-Cause and Cardiovascular Mortality.血液透析后体重高于和低于目标体重与全因死亡率和心血管死亡率的关联。
Clin J Am Soc Nephrol. 2015 May 7;10(5):808-16. doi: 10.2215/CJN.10201014. Epub 2015 Apr 10.
10
Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy.在竞争风险框架下估计标准化风险差异和比率:应用于注射吸毒及开始抗逆转录病毒治疗后进展为艾滋病的情况。
Am J Epidemiol. 2015 Feb 15;181(4):238-45. doi: 10.1093/aje/kwu122. Epub 2014 Jun 24.